Home › Funds › Steadfast Capital Management › REGN
Steadfast Capital Management position in REGN
REGENERON PHARMACEUTICALS · Health Care
Latest position (Q4 2025)35.20K sh
Reported value held$27.17M
Portfolio Weight0.47%
First reportedQ4 2025
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 35.20K | $27.17M | New |
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026
- AQR Capital Management 1.13M sh · $702.16M · Q2 2026